Decoding Biotech: A Deep Dive into AI and Platform Technologies

Kiersten Stead, Co-Founder and Managing Partner of DCVC Bio discusses her firm’s approach to deep tech investing in biotech and focus on platform technologies. They delve into the intersection of in vivo CAR-T therapy and AI in healthcare, the challenges of developing safe and effective drugs, and the importance of science and team in biotech. The chapter also emphasizes the value of combining data, people, and technology to gain insights.